Patents by Inventor Garry George Graham

Garry George Graham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of inhibiting prostate cancer cell proliferation
    Publication number: 20110195915
    Abstract: The present invention relates to a method of inhibiting or reducing the proliferation of prostate cancer cells, such as androgen independent prostate cancer (AIPC) cells, the method comprising administering to the cells a PLA2 inhibitor. In one embodiment the PLA2 inhibitor is a conformationally constrained molecule derived from a peptide consisting essentially of amino acid residues 70-74 of a human sPLA2-IIA protein, or the equivalent residues in other sPLA2 proteins.
    Type: Application
    Filed: February 14, 2011
    Publication date: August 11, 2011
    Applicant: Scott, Kieran, Francis
    Inventors: Garry George Graham, Qihan Dong
  • Method of inhibiting prostate cancer cell proliferation
    Patent number: 7919458
    Abstract: The present invention relates to a method of inhibiting or reducing the proliferation of prostate cancer cells, such as androgen independent prostate cancer (AIPC) cells, the method comprising administering to the cells a PLA2 inhibitor. In one embodiment the PLA2 inhibitor is a conformationally constrained molecule derived from a peptide consisting essentially of amino acid residues 70-74 of a human sPLA2-IIA protein, or the equivalent residues in other sPLA2 proteins.
    Type: Grant
    Filed: June 10, 2003
    Date of Patent: April 5, 2011
    Assignee: Scott, Kieran, Francis
    Inventors: Garry George Graham, Qihan Dong
  • Method of Inhibiting Prostate Cancer Cell Proliferation
    Publication number: 20080113343
    Abstract: The present invention relates to a method of inhibiting or reducing the proliferation of prostate cancer cells, such as androgen independent prostate cancer (AIPC) cells, the method comprising administering to the cells a PLA2 inhibitor. In one embodiment the PLA2 inhibitor is a conformationally constrained molecule derived from a peptide consisting essentially of amino acid residues 70-74 of a human sPLA2-IIA protein, or the equivalent residues in other sPLA2 proteins.
    Type: Application
    Filed: June 10, 2003
    Publication date: May 15, 2008
    Inventors: Garry George Graham, Qihan Dong